Login / Signup

Quality improvement initiative to improve revaccination rates after autologous stem cell transplantation.

Corina DeKrakerAustin Joseph KempAllana SimonCristian ReyHenry ChengZara KianiAdrienne FulfordSue NugentDenise SinghUday Deotare
Published in: BMJ open quality (2022)
Keyphrases
  • stem cell transplantation
  • quality improvement
  • high dose
  • patient safety
  • bone marrow
  • cell therapy
  • platelet rich plasma
  • low dose
  • mesenchymal stem cells